{"id":"W3017596149","doi":"10.1111/cas.14430","title":"Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients","year":2020,"lang":"en","type":"article","venue":"Cancer Science","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Novartis Japan","keywords":"Nilotinib; Medicine; Myeloid leukemia; Tyrosine-kinase inhibitor; Internal medicine; Population; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593895,0.0003206036,0.0008045469,0.0005711103,0.00008957157,0.00002283984,0.0004841419,0.00009496901,0.0005522514],"category_scores_gemma":[0.0003383894,0.0002326105,0.0002574142,0.006190161,0.0003881262,0.0002703606,0.0001459282,0.0001493683,0.00001751908],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01931981,"about_ca_system_score_gemma":0.005332479,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007545835,"about_ca_topic_score_gemma":0.0005016811,"domain_scores_codex":[0.9973787,0.00004091103,0.000508299,0.0008220333,0.0006565474,0.0005934776],"domain_scores_gemma":[0.9980878,0.00005976412,0.000254184,0.0008180435,0.0002241455,0.0005560255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004397728,0.0002156112,0.9291224,0.00006963265,0.0005169233,0.00003598328,0.002558497,0.003536841,0.04877638,0.000002746014,0.0002855065,0.01443968],"study_design_scores_gemma":[0.009101263,0.00250315,0.9172471,0.0001956414,0.001174354,0.000002996273,0.0001036121,0.03274056,0.03639999,0.000003184668,0.0002555975,0.0002725132],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970718,0.0007821228,0.000003231314,0.0002602795,0.00007632635,0.0005620222,0.0001228781,0.00005581729,0.001065505],"genre_scores_gemma":[0.9989348,0.0003840586,0.00009020987,0.0001441354,0.00006648817,0.00004843286,0.00008564402,0.0000219231,0.0002243289],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02920372,"threshold_uncertainty_score":0.999063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02238252583623937,"score_gpt":0.3183473209959485,"score_spread":0.2959647951597091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}